期刊文献+

不同方法检测血清特定蛋白的结果一致性研究 被引量:6

Harmonization of serum protein measurements with different immunoassays
原文传递
导出
摘要 目的 分析不同检测系统、方法间特定蛋白检测结果的差异;探讨以欧洲标准局参考物质(ERM) DA470k/IFCC赋值的定值血清能否替代ERM-DA470k/IFCC应用于临床检测以促进特定蛋白检测结果一致性.方法 方法学评价.选取2012年6月于复旦大学附属中山医院体检中心进行健康体检的表面健康人群(27 ~ 73岁,男47名,女53名)血清标本100份.我们使用罗氏和德赛试剂在日立7600全自动生化仪、西门子试剂在西门子BNⅡ特定蛋白仪和贝克曼试剂在贝克曼IMMAGE特定蛋白仪检测100份血清标本、ERM-DA470k/IFCC以及ERM-DA470k/IFCC赋值的定值血清标本中的IgA、IgG、IgM、补体3c(C3c)、补体4(C4)、转铁蛋白(TRF)和前白蛋白(PA)含量.以ERM-DA470k/IFCC为校准品对混合血清进行定值.同类方法间特定蛋白检测结果比较使用T检验和Wilcoxon非参数检验,不同方法间结果比较使用方差分析和Friedman非参数检验.两组数据相关性分析采用一元线性回归分析.结果 两种免疫散射比浊检测方法之间、两种免疫透射比浊检测方法之间以及4种免疫比浊法之间特定蛋白检测结果均存在统计学差异(P<0.05).2种免疫透射比浊检测方法之间除C3c以外其余项目的R2均>0.97,相关性较好.2种免疫散射比浊检测方法之间除IgM结果的R2> 0.96外,其余项目结果的R2均在0.90 ~0.94,相关性相对略差.不同免疫比浊法IgA、IgG和IgM结果间相关性较好,R2均>0.95;C3c、C4、TRF和PA结果间相关性相对略差,R2为0.90~0.97.以ERM-DA470k/IFCC标定值为基准,对各检测系统的特定蛋白检测结果进行修正后,检测值可趋于一致(P>0.05);定值血清也可以取得相似的效果.结论 不同检测系统(方法)间特定蛋白检测结果存在明显差异.ERM-DA470k/IFCC和定值血清能够修正不同检测系统(方法)间特定蛋白检测结果,使检测值趋于一致. Objective To analyze differences of serum proteins measurements by different methods in different systems and investigate whether the assigned serum valued by ERM-DA470k/IFCC can replace ERM-DA470k/IFCC in clinical measurements to promote the harmonization of serum proteins measurements. Methods Serum specimen was collected from 100 medical examination persons in Zhongshan Hospital ( Jun 2012; age: 27-73; 47 male and 53 female). Serum IgA, IgG, IgM, C3e, C4, TRF and PA of health persons, ERM-DA470k/IFCC and the assigned valued by ERM-DA470k/IFCC were measured by Hitachi 7600 (Roche and DiaSys reagents), Siemens BN II (Siemens reagent) and Beckman IMMAGE (Beckman reagent), respectively. ERM-DA470k/IFCC was used as a calibrator to value the mixed serum. Serum proteins results obtained from the same methods were compared by T test and Wilcoxon test, and analysis of variance and Firendman test were used to compare results from different methods. The correlation of two groups was analyzed by linear regression. Results The differences of serum proteins results measured by two immunonephelometries, two immunoturbidimetries and all assays were statistically significant (P 〈 0. 05), respectively. The serum proteins results measured by two immunoturbidimetries showed good correlation (R2 were all above 0. 97 except for C3c). In contrast, the serum proteins results measured by twoimmunonephelometries show poor correlation (R2 were all ranged from 0. 90 to 0. 94) except for IgM ( above 0. 96 ). The serum IgA, IgG and IgM results measured by different methods show good correlation (R2 were all above 0. 95 ) Based on certified values of ERM-DA470k/IFCC, serum protein results measured by different methods could be harmonized, and got similar results from the assigned serum ( P 〉 0. 05 ) . Conclusions There is significant difference of serum proteins results detected by different methods. The ERM-DA470k/IFCC and certified serum can make serum protein results obtained from different methods harmonized.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2013年第9期839-844,共6页 Chinese Journal of Laboratory Medicine
基金 2010年国家临床重点专科建设项目
关键词 血蛋白质类 参考标准 可重复性 结果 Blood proteins Reference standards Reproducibility of results
作者简介 通信作者:潘柏申,电子信箱:pan.baishen@zs—hospital.sh.cn
  • 相关文献

参考文献7

  • 1Baudner S, Bienvenu J,Blirup-Jensen S,et al. The certification ofa matrix reference material for immunochemical measurement of 14human serum proteins-CRM470. EUR: Luxembourg, 1993.
  • 2Certification of proteins in the human serum Certified ReferenceMaterial ERM-DA470k/IFCC. EUR,2008.
  • 3Bienvenu J,Doche C,Later R,et al. Dumont G. Improvements fromthe reference material CRM 470 in the standardization of thedetermination of serum proteins. Ann Biol Clin ( Paris),1997 ,55 :37-40.
  • 4Zegers I,Keller T,Schreiber W,et al. Characterization of the newserum protein reference material ERM-DA470k/IFCC : valueassignment by immunoassay. Clin Chem,2010,56 : 1880-1888.
  • 5李金明.免疫测定技术的临床应用及应注意的问题[J].中华检验医学杂志,2008,31(11):1205-1208. 被引量:12
  • 6Chambers RE,Bullock DG,Whicher JT. Improved between-laboratory agreement for specific protein assays in serum followingintroduction of a common reference preparation ( SPS-01 )demonstrated in an external quality assessment scheme. Clin ChimActa,1987,164: 189-200.
  • 7Johnson AM, Whicher JT. Effect of certified reference material 470(CRM 470 ) on national quality assurance programs for serumproteins in Europe. Clin Chem Lab Med,2001,39 : i 123-i 128.

二级参考文献23

  • 1刘玲芝,刘志洪,何治柯,蔡汝秀.量子点:FRET的新发展[J].化学进展,2006,18(2):337-343. 被引量:10
  • 2李金明.乙型肝炎病毒血清标志物测定及结果解释的若干问题[J].中华检验医学杂志,2006,29(5):385-389. 被引量:154
  • 3李金明.感染性疾病血清学检验中应重视对弱反应性标本的确认[J].中华检验医学杂志,2006,29(7):577-580. 被引量:126
  • 4Evans MI, O'Brien JE, Dvorin E, et al. Standardization of methods reduces variability: explanation for historical discrepancies in biochemical screening. Genet Test, 2003,7:81-83.
  • 5Ledae TB, Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement : implications for cardiovascular disease risk assessment. Clin Chem, 2003,49 : 1258-1271.
  • 6van Weeman BK, Schuurs AH. Immunoassay using antigen-enzyme conjugates. FEBS Lett, 1971,15:232-236.
  • 7Engvall E, Perlmann P. Enzyme-linked immanosorbant assay (ELISA). Quantitative assay for immunoglobulin G. Immunochemistry, 1971,8:871.
  • 8Avrarneas S. Historical background of the invention of EIA and ELISA. Clin Chem, 2006,52:1430-1431.
  • 9van Weemen BK. The rise of EIA/ELISA. Clin Chem, 2005,51:2226.
  • 10Engvall E. Perspective on the historical note on EIA/ELISA by Dr. R.M. Lequin. Clin Chem, 2005,51:2225.

共引文献11

同被引文献60

  • 1王前,郑磊,曾方银.超敏C-反应蛋白的研究现状及临床应用[J].中华检验医学杂志,2004,27(8):542-544. 被引量:193
  • 2赵国庆,冉玉平,杨伯艳.丘疹性荨麻疹病因学系统评价[J].中华皮肤科杂志,2006,39(4):213-215. 被引量:34
  • 3荨麻疹诊疗指南(2007版)[J].中华皮肤科杂志,2007,40(10):591-593. 被引量:217
  • 4李海霞,王学晶,徐国宾,李淑葵,夏铁安.两种不同检测系统测定半胱氨酸蛋白酶抑制剂C的方法学评价[J].中华检验医学杂志,2007,30(11):1284-1287. 被引量:16
  • 5Trnka P. Henoch-Schtinlein purpura in children [ J ]. J Paediatr Child Health, 2013, 49( 12): 995-1003. S.
  • 6hi JS, Gu JY, Wang M. Clinical manifestations,gastroscopic and pathological features of abdominal type Henoch-Schonlein pnrpnra in children[J]. Pediatric Nephrology, 2013, 28 : 1424.
  • 7Park SJ, Suh JS, Lee JH, et al. Advances in our understanding of the pathogenesis of Henoch-Schnlein purpura and the implications for improving its diagnosis[J]. Expert Rev Clin Immunol, 2013, 9(12) : 1223-1238.
  • 8Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria[J]. Ann Rheum Dis, 2010, 69(5) : 798-806.
  • 9Soong J, Soni N. Sepsis: recognition and treatment [ J ]. Clin Med, 2012, 12(3) : 276-280.
  • 10Neunert C, Lira W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thmmbocytopenia[J].Blood, 2011,117 (16) : 4190-4207.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部